The mechanism behind the reduced survival in these patients warrants further research and has yet to be elucidated by in vitro research and by specifically designed, prospective studies that address the prognostic role of RRM2 and TS expression in NSCLC resected patients. The gene discussed is TYMS; the disease is non-small cell lung carcinoma.